Literature DB >> 9826214

Enteral ornithine alpha-ketoglutarate enhances intestinal adaptation to massive resection in rats.

F Dumas1, J P De Bandt, V Colomb, J Le Boucher, C Coudray-Lucas, S Lavie, N Brousse, C Ricour, L Cynober, O Goulet.   

Abstract

Ornithine alpha-ketoglutarate (OKG) has been advocated in the treatment of critically ill patients for its anabolic effect on protein metabolism. Since OKG is a precursor of glutamine, arginine, and polyamines, key substrates of intestinal metabolism and function, we investigated the influence of OKG on intestinal adaptation and trophicity and on glutamine status after small bowel resection. After massive (80%) small bowel resection, rats were enterally fed for 7 days with a standard diet supplemented with either OKG (2 g/kg/d) or an isonitrogenous amount of glycine. OKG induced an adaptative hyperplasia of the villi, demonstrated in the jejunum by an increase in the villus height to crypt depth ratio (OKG v control, 4.3+/-0.4 v 3.3+/-0.5, P < .01) along with an increase (P < .05) in ornithine decarboxylase (ODC) activity (+80%) and ornithine content (+102%). Plasma glutamine (+25%) and muscle glutamine (anterior tibialis [AT], +43%; extensor digitorum longus [EDL], +54%) and protein (AT, +32%) were significantly higher (P < .05) after OKG administration, supporting its role in the restoration of glutamine pools. In summary, enterally administered OKG, which enhances intestinal adaptation after massive resection and improves muscle glutamine and protein content, could contribute significantly to nutritional management after small bowel resection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9826214     DOI: 10.1016/s0026-0495(98)90306-7

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  6 in total

Review 1.  Intestinal mucosal adaptation.

Authors:  Laurie Drozdowski; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

2.  Parenteral arginine impairs intestinal adaptation following massive small bowel resection in a rat model.

Authors:  Igor Sukhotnik; Jorge G Mogilner; Aaron Lerner; Arnold G Coran; Michael Lurie; Iness Miselevich; Eitan Shiloni
Journal:  Pediatr Surg Int       Date:  2005-05-26       Impact factor: 1.827

Review 3.  The management of patients with the short bowel syndrome.

Authors:  Cameron F E Platell; Jane Coster; Rosalie D McCauley; John C Hall
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

Review 4.  Morphological, kinetic, membrane biochemical and genetic aspects of intestinal enteroplasticity.

Authors:  Laurie A Drozdowski; M Tom Clandinin; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

Review 5.  Intestinal mucosal atrophy and adaptation.

Authors:  Darcy Shaw; Kartik Gohil; Marc D Basson
Journal:  World J Gastroenterol       Date:  2012-11-28       Impact factor: 5.742

Review 6.  Alpha-Ketoglutarate as a Molecule with Pleiotropic Activity: Well-Known and Novel Possibilities of Therapeutic Use.

Authors:  Barbara Zdzisińska; Aleksandra Żurek; Martyna Kandefer-Szerszeń
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2016-06-20       Impact factor: 4.291

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.